Literature DB >> 23303528

Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ.

Anne Jørgensen1, John E Nielsen, Kristian Almstrup, Birgitte Grønkær Toft, Bodil Laub Petersen, Ewa Rajpert-De Meyts.   

Abstract

Testicular germ cell tumours (TGCT) of young adults arise from the intratubular precursor, carcinoma in situ (CIS). CIS cells are thought to be developmentally arrested and transformed fetal germ cells that survive through childhood and gain invasive capacity after puberty. Given that germ cell neoplasms arise frequently in undervirilized and dysgenetic gonads and the striking physiological difference between meiotic entry in ovaries (fetal life) versus testes (at puberty), this study aimed to investigate whether errors in regulation of meiosis may be implicated in the pathogenesis of CIS or its invasive progression to TGCT. The main focus was on a key sex differentiation and meiosis regulator, DMRT1, which has also been linked to TGCT risk in recent genetic association studies. Expression patterns of DMRT1 and other meiosis regulators (SCP3, DMC1, STRA8, CYP26B1, NANOS2, NANOS3) were investigated in pre- and post-pubertal CIS samples and TGCT by quantitative RT-PCR and immunohistochemistry. The results demonstrated that meiosis markers and meiosis inhibitors were simultaneously expressed in CIS cells, in both pre- and post-pubertal testis samples. DMRT1 was present in a restricted subset of CIS cells, which was relatively greater in pre-pubertal (27%) compared to adult (2.6%) samples. In contrast to the majority of CIS cells, DMRT1-positive CIS cells in adult testes were not proliferating. DMRT1 and most of the other meiosis regulators were absent or expressed at low levels in invasive TGCT, except in spermatocytic seminoma (not derived from CIS). In conclusion, this study indicates that meiosis signalling is dysregulated in CIS cells and that a key regulator of the mitosis-meiosis switch, DMRT1, is expressed in 'early-stage' CIS cells but is down-regulated with further invasive transformation. Whether this mixed meiosis signalling in CIS cells is caused by insufficient virilization of the fetal somatic niche or a partial post-pubertal maturation remains uncertain and requires further study.
Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303528     DOI: 10.1002/path.4154

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  25 in total

Review 1.  [Spermatocytic seminoma. A tumor with many faces].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

2.  Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.

Authors:  Jirina Bartkova; Christina E Hoei-Hansen; Katerina Krizova; Petra Hamerlik; Niels E Skakkebæk; Ewa Rajpert-De Meyts; Jiri Bartek
Journal:  Mol Oncol       Date:  2014-07-09       Impact factor: 6.603

3.  Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation.

Authors:  Denise G Lanza; Emily P Dawson; Priya Rao; Jason D Heaney
Journal:  Cell Cycle       Date:  2016-02-22       Impact factor: 4.534

Review 4.  Germ cell tumors: Insights from the Drosophila ovary and the mouse testis.

Authors:  Helen K Salz; Emily P Dawson; Jason D Heaney
Journal:  Mol Reprod Dev       Date:  2017-03       Impact factor: 2.609

Review 5.  Molecular biology of testicular germ cell tumors.

Authors:  R Gonzalez-Exposito; M Merino; C Aguayo
Journal:  Clin Transl Oncol       Date:  2015-10-19       Impact factor: 3.405

6.  Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.

Authors:  Christiane Rudolph; Cecilie Melau; John E Nielsen; Kristina Vile Jensen; Dekang Liu; Javier Pena-Diaz; Ewa Rajpert-De Meyts; Lene Juel Rasmussen; Anne Jørgensen
Journal:  Cell Oncol (Dordr)       Date:  2017-05-23       Impact factor: 6.730

7.  Genomic evolution and chemoresistance in germ-cell tumours.

Authors:  Amaro Taylor-Weiner; Travis Zack; Elizabeth O'Donnell; Jennifer L Guerriero; Brandon Bernard; Anita Reddy; G Celine Han; Saud AlDubayan; Ali Amin-Mansour; Steven E Schumacher; Kevin Litchfield; Clare Turnbull; Stacey Gabriel; Rameen Beroukhim; Gad Getz; Scott L Carter; Michelle S Hirsch; Anthony Letai; Christopher Sweeney; Eliezer M Van Allen
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

8.  Ex vivo culture of human fetal gonads: manipulation of meiosis signalling by retinoic acid treatment disrupts testis development.

Authors:  A Jørgensen; J E Nielsen; S Perlman; L Lundvall; R T Mitchell; A Juul; E Rajpert-De Meyts
Journal:  Hum Reprod       Date:  2015-08-06       Impact factor: 6.918

9.  Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors.

Authors:  Roelof Koster; Nandita Mitra; Kurt D'Andrea; Saran Vardhanabhuti; Charles C Chung; Zhaoming Wang; R Loren Erickson; David J Vaughn; Kevin Litchfield; Nazneen Rahman; Mark H Greene; Katherine A McGlynn; Clare Turnbull; Stephen J Chanock; Katherine L Nathanson; Peter A Kanetsky
Journal:  Hum Mol Genet       Date:  2014-06-18       Impact factor: 6.150

Review 10.  The chemosensitivity of testicular germ cell tumors.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2014-04-02       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.